"Our long-term goal is to have one million persons stand and walk in Ekso exoskeletons by February 2022. The first step to achieving that goal is for us to focus on selling our medical exoskeletons to rehabilitation centers and hospitals in the United States and Europe. Ekso Bionics began that effort with the February 2012 sale of Ekso, an exoskeleton for complete spinal cord injuries (“SCI”). We have expanded that effort with the launch of our Variable Assist software and the announcement of our newest hardware platform, Ekso GT. The Variable Assist software enables users with any amount of lower extremity strength to contribute their own power for either leg to achieve self-initiated walking. The Ekso GT builds on the experience of the Ekso and incorporates Variable Assist, allowing us to expand our sales and marketing efforts beyond SCI-focused centers to centers supporting stroke and related neurological patients. In the U.S. there are about 5.9 million stroke and SCI rehabilitation sessions conducted on about 680,000 stroke and SCI patients at 16,900 facilities. Globally, there are an estimated 50,000 rehabilitation facilities"
One million people that have used the device before 2022 does not mean 1,000,000 sales. A single device built today could be used by thousands of people before 2022.
Even if Ekso was in all 50,000 rehabilitation facilities and every single facility bought 4 units - you would still be only 1/5 of the way to your sales estimate. I think we can agree that 1,000,000 unit sales is ridiculous (at least for the Ekso GT). If Ekso is going to hit their goal of one million total users, they will need many personal units and we have no way to predict what these will cost.
